Panbela Therapeutics Total Assets

Panbela Therapeutics posts a total assets of $5.2M as of September 2024. That compares with $11M in the prior-year period — down 51.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Panbela Therapeutics's total assets was $11M. The latest reading is $5.2M — a 51.4% year-over-year decrease (period ending September 2024). Use the history and growth charts on this page for a longer lookback.

Total Assets is one piece of Panbela Therapeutics's financial statement story. At $5.2M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for PBLA's total assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Panbela Therapeutics's other metric pages and overview cover the third.

Judging Panbela Therapeutics against Technology peers is usually better than using a market-wide rule of thumb. Business models inside Technology are more comparable, which makes gaps in total assets easier to interpret. Start with $5.2M here, then scan peer and history charts to see if the gap is persistent.